News & Events
Markowitz gets $875,000 funding over five years — and the freedom to take risks and explore new frontiers in his research.
School of Biological Sciences’ research tests widely-held medical hypothesis
Annual funding program supports diverse range of interdisciplinary research projects
Cancer research pioneer Carl June delivers first J. David Allen Keynote Lecture
Georgia Tech leading the effort to develop manufacturing expertise and expand cell therapies
McDonald’s cancer research gets a boost from Nanotechnology Characterization Laboratory
Petit Institute researcher Susan Thomas awarded funding from It’s the Journey and Georgia CORE
Sharing is caring in the fight against cancer with this new open source software project to predict cancer drug effectiveness.
Santangelo lab makes startling discovery in research of common, widespread virus.
A new study has produced a set of biomarkers that may enable development of an accurate ovarian cancer screening test.
New research by Georgia Tech scientists underscores importance of gene regulation
Ovarian cancer research indicates that cells undergo genetic changes while spreading.
Researchers are developing a technique for predicting the amount of protein-degrading enzymes a specific person would produce.
New Georgia Tech research shows that cell stiffness could be a valuable clue for doctors as they search for and treat cancerous cells before they’re able to spread.
Researchers for the first time have shown that enzymes that normally degrade proteins may attack each other instead.
Researchers have designed a new treatment approach that appears to halt the spread of cancer cells into normal brain tissue in animal models.
Georgia Tech has created a new data analysis algorithm that quickly transforms complex RNA sequence data into usable content for cancer biologists and clinicians.
Study identifies two mechanisms cells use to remove RNA from DNA.
Researchers at Georgia Tech are using hydrogel nanoparticles to kill cancer cells
